
Overview
Runi Chattopadhyay is a General Surgeon in Palo Alto, California. Dr. Chattopadhyay is rated as an Experienced provider by MediFind in the treatment of Li-Fraumeni Syndrome. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Intraductal Papilloma, Angiosarcoma, and Lymphadenectomy. Dr. Chattopadhyay is currently accepting new patients.
Her clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- MEDICARE SNP
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- HMO
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Palo Alto, CA 94301
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Stanford Health Care
Kimberly Stone is a General Surgeon in Stanford, California. Dr. Stone is rated as a Distinguished provider by MediFind in the treatment of Li-Fraumeni Syndrome. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, and Lymphadenectomy.
Stanford Health Care
Jacqueline Tsai is a General Surgeon in Stanford, California. Dr. Tsai is rated as a Distinguished provider by MediFind in the treatment of Li-Fraumeni Syndrome. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, Mastectomy, and Lymphadenectomy.
Stanford Health Care
Dung Nguyen is a General Surgeon and a Plastic Surgeon in Stanford, California. Dr. Nguyen is rated as a Distinguished provider by MediFind in the treatment of Li-Fraumeni Syndrome. Her top areas of expertise are Primary Intestinal Lymphangiectasia, Meige Disease, Lymphedema, Fasciotomy, and Lymphadenectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- AngiosarcomaDr. Chattopadhyay isAdvanced. Learn about Angiosarcoma.
- Breast CancerDr. Chattopadhyay isAdvanced. Learn about Breast Cancer.
- Intraductal PapillomaDr. Chattopadhyay isAdvanced. Learn about Intraductal Papilloma.
- LymphadenectomyDr. Chattopadhyay isAdvanced. Learn about Lymphadenectomy.
- Paget Disease of the BreastDr. Chattopadhyay isAdvanced. Learn about Paget Disease of the Breast.
- Experienced
- BRCA Positive Breast CancerDr. Chattopadhyay isExperienced. Learn about BRCA Positive Breast Cancer.
- Breast Cancer in MenDr. Chattopadhyay isExperienced. Learn about Breast Cancer in Men.
- Breast LumpDr. Chattopadhyay isExperienced. Learn about Breast Lump.
- FibroadenomaDr. Chattopadhyay isExperienced. Learn about Fibroadenoma.
- Giant Mammary HamartomaDr. Chattopadhyay isExperienced. Learn about Giant Mammary Hamartoma.
- HER-2 Positive Breast CancerDr. Chattopadhyay isExperienced. Learn about HER-2 Positive Breast Cancer.
